Charles River Laboratories International, Inc. Common Stock (NY:CRL)

376.10 +2.12 (+0.57%)

Official Closing Price Updated: 6:30 PM EDT, Oct 29, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Charles River Laboratories International, Inc. Common Stock

< Previous 1 2

...

9 10 11 12 13 14 15 16 17

...

23 24 Next >

These Nike Analysts Are No Longer Bullish; Here Are Top 5 Downgrades For Friday ↗

June 28, 2024

Via Benzinga

Demystifying Charles River: Insights From 4 Analyst Reviews ↗

June 28, 2024

Via Benzinga

Charles River Laboratories Announces Strategic Lentiviral Vector Manufacturing Collaboration with Gates Institute at University of Colorado Anschutz Medical Campus

June 25, 2024

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River and Captain T Cell Announce Plasmid DNA and Viral Vector Manufacturing Alliance for Gene-Modified Cell Therapy

June 17, 2024

From Charles River Laboratories International, Inc.

Via Business Wire

The Analyst Verdict: Charles River In The Eyes Of 4 Experts ↗

June 06, 2024

Via Benzinga

The Analyst Landscape: 7 Takes On Charles River ↗

May 10, 2024

Via Benzinga

Charles River Laboratories, in Collaboration With MatTek Corporation, Awarded Grant from the Foundation for Chemistry Research and Initiatives to Advance Research Alternatives

June 11, 2024

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Laboratories Expands Access to CRADL® Contract Vivarium Space in Somerville

June 06, 2024

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Laboratories Announces Development of Nonclinical Virtual Control Groups with Sanofi to Reduce the Use of Animals in Research

June 04, 2024

From Charles River Laboratories International, Inc.

Via Business Wire

Evaluating Charles River: Insights From 7 Financial Analysts ↗

March 18, 2024

Via Benzinga

Charles River Laboratories to Present at William Blair and Jefferies Conferences

June 03, 2024

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Launches Viral Vector Tech Transfer Program to Safeguard Gene Therapy Development

May 30, 2024

From Charles River Laboratories International, Inc.

Via Business Wire

CRL Stock Earnings: Charles River Beats EPS, Beats Revenue for Q1 2024 ↗

May 09, 2024

CRL stock results show that Charles River beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

Charles River Laboratories Announces First-Quarter 2024 Results

May 09, 2024

From Charles River Laboratories International, Inc.

Via Business Wire

The 7 Best Growth Stocks to Buy in May 2024 ↗

May 08, 2024

Find real bargains in this marketplace with these seven best growth stocks to buy today for your portfolio.

Via InvestorPlace

10 Health Care Stocks With Whale Alerts In Today's Session ↗

May 07, 2024

Via Benzinga

Charles River Launches Viral Vector Reference Materials to Streamline the Transition to GMP

May 02, 2024

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Laboratories Achieves 100% Renewable Electricity Usage Globally

April 22, 2024

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal Testing

April 16, 2024

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call

April 12, 2024

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology

April 11, 2024

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics

April 09, 2024

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River to Perform Plasmid Production for Ship of Theseus

April 04, 2024

From Charles River Laboratories International, Inc.

Via Business Wire

CHARLES RIVER ALERT: Bragar Eagel & Squire, P.C. is Investigating Charles River Laboratories International, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

April 02, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

Charles River Laboratories Showcases Technology-Driven Capabilities at AACR 2024

April 01, 2024

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Laboratories Publishes 2023 Corporate Citizenship Report

March 27, 2024

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Announces Extension of Gene Therapy Manufacturing Alliance with NUS Yong Loo Lin School of Medicine

March 21, 2024

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River and Navega Therapeutics Announce Comprehensive Gene Therapy Manufacturing Collaboration

March 14, 2024

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Laboratories to Present at Barclays Global Healthcare Conference

March 12, 2024

From Charles River Laboratories International, Inc.

Via Business Wire

The Top 3 Healthcare Stocks to Buy in March 2024 ↗

March 07, 2024

There are still bargains to be had in the medical space. These are three top healthcare stocks to buy today.

Via InvestorPlace

< Previous 1 2

...

9 10 11 12 13 14 15 16 17

...

23 24 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.